Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2019-12-30 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider ....
Regulatory Filings
2019-12-30 English
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the ....
Regulatory Filings
2019-12-20 English
Price movement
Regulatory Filings Classification · 90% confidence The document text contains only a placeholder for an omitted picture and has a very short length (51 characters). There is no substantive content, no financial data, no report title, no regulatory references, or any other information to classify it as a specific report type. Given the extremely limited content and lack of any report or announcement details, the document cannot be classified as a report or announcement. It falls under the fallback category of Regulatory Filings (RNS) due to lack of specific information.
2019-12-20 English
Resignation
Regulatory Filings
2019-12-20 English
This is to inform you that Mr. Abhishek D. Buddhadev, Company Secretary and Compliance Officer of the Company has resigned from the said position with effect from closing of working hours ....
Regulatory Filings
2019-12-20 English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 11, 2019 for Nehal N Gandhi
Regulatory Filings
2019-12-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.